Josie Hayes, Ph.D.

Dr. Josie Hayes is a seasoned expert in translational medicine and predictive diagnostics, with 20 years of experience in oncology diagnosis and research. Her career spans clinical diagnostics, bioinformatics, biomarkers, and experimental molecular biology, making her a trusted leader in the field.

Josie is the founder of Hayes Consulting LLC, where she provides strategic guidance on biomarker strategy and evaluation, lean translational operations, predictive and pharmacodynamic biomarkers, and assay development. Her work supports clients through all stages of drug development, from hypothesis generation to patient application. She is highly skilled in computational biology, biostatistics, real-world evidence analysis, and TCGA biomarker mining, offering insights that have directly influenced clinical decision-making.

Previously, Josie held leadership positions in prominent biotech firms such as Revolution Medicines and an immuno-oncology stealth start-up, where she spearheaded translational medicine strategies, managed cross-functional teams, and contributed to clinical trial protocols, IND filings, and investigator brochures. Her work has included developing early development biomarker and companion diagnostics strategies, designing complex biomarker-related mouse clinical trials, and establishing robust RNA-seq and exome sequencing pipelines.

Josie's expertise extends beyond industry roles; she has conducted postdoctoral research at UC Berkeley and UCSF, focusing on biostatistics, neurological surgery, and bioinformatics. Her academic achievements include a PhD from the University of Leeds in collaboration with Harvard Medical School, with her research yielding several highly cited publications.

An accomplished author, Josie published 'Confront Cancer: Tools to Make the Right Decisions for Your Cancer,' reflecting her commitment to empowering patients with actionable knowledge. Known for her communication skills, attention to detail, honesty, leadership, and professionalism, she is also well-connected within the biotech community, fostering collaborations that ensure value for money and high-quality outcomes.

Josie continues to drive innovation in biomarker discovery and clinical application, helping biotech companies bridge the gap between scientific discovery and clinical success.